BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer…
Blunt to speak on the importance of understanding psilocybin’s potential role in mental health, reducing barriers to continued research in…
Marks 29 Patents Worldwide Directed to Biora’s Device Localization TechnologySAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc.…
WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced U.S. Food and Drug Administration (FDA)…
Microsoft Executive Parul Bhandari Brings Digital Transformation Expertise to BoardLINCOLN, Neb., May 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation,…
SAN FRANCISCO, May 19, 2022 (GLOBE NEWSWIRE) -- Headlands Research, a leading international network of clinical trial sites, announced today…
MIAMI, May 19, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a…
Company name change reflects mission to address significant unmet needs in rare cancer therapeutics, returning to company rootsCranbury, NJ, May…
All 23 treated patients are alive at 2.6-year median follow-up without evidence of malignant transformation Data representing largest cohort of…
Toro Lateral (Toro-L) Interbody Fusion System Accelus announced today that it had received U.S. FDA 510(k) Clearance for its Toro-L…